Predict your next investment

Venture Capital
omx.vc

See what CB Insights has to offer

Investments

5

Portfolio Exits

1

Funds

1

About OMX Ventures

OMX Ventures invest at the convergence of biology and computing.

OMX Ventures Headquarter Location

Chicago, Illinois,

United States

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest OMX Ventures News

Delix Therapeutics Closes USD 70M Series A

Sep 28, 2021

Preclinical neuroscience company Delix Therapeutics, today announced the closing of a USD 70 million Series A financing round. The round was led by ARTIS Ventures, RA Capital Management, and founding investor OMX Ventures, with participation from a diverse syndicate of life sciences and psychedelic investment funds.

OMX Ventures Investments

5 Investments

OMX Ventures has made 5 investments. Their latest investment was in Mythic Therapeutics as part of their Series B on December 12, 2021.

CBI Logo

OMX Ventures Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

12/15/2021

Series B

Mythic Therapeutics

$103M

Yes

3

9/27/2021

Series A

Subscribe to see more

$99M

Subscribe to see more

10

7/8/2021

Seed VC

Subscribe to see more

$99M

Subscribe to see more

10

9/17/2020

Series C

Subscribe to see more

$99M

Subscribe to see more

10

6/23/2020

Series A - II

Subscribe to see more

$99M

Subscribe to see more

10

Date

12/15/2021

9/27/2021

7/8/2021

9/17/2020

6/23/2020

Round

Series B

Series A

Seed VC

Series C

Series A - II

Company

Mythic Therapeutics

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Amount

$103M

$99M

$99M

$99M

$99M

New?

Yes

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

3

10

10

10

10

OMX Ventures Portfolio Exits

1 Portfolio Exit

OMX Ventures has 1 portfolio exit. Their latest portfolio exit was Finch Therapeutics on March 19, 2021.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

3/19/2021

IPO

$99M

1

Date

3/19/2021

Exit

IPO

Companies

Valuation

$99M

Acquirer

Sources

1

OMX Ventures Fund History

1 Fund History

OMX Ventures has 1 fund, including OMX Ventures Fund I.

Closing Date

Fund

Fund Type

Status

Amount

Sources

3/22/2021

OMX Ventures Fund I

$150M

2

Closing Date

3/22/2021

Fund

OMX Ventures Fund I

Fund Type

Status

Amount

$150M

Sources

2

OMX Ventures Team

2 Team Members

OMX Ventures has 2 team members, including current Managing Director, Craig Asher.

Name

Work History

Title

Status

Craig Asher

Managing Director

Current

Daniel Fero

Merieux Equity Partners, and L.E.K. Consulting

Managing Director

Current

Name

Craig Asher

Daniel Fero

Work History

Merieux Equity Partners, and L.E.K. Consulting

Title

Managing Director

Managing Director

Status

Current

Current

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.